Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BDB554676

IL-3 Rat anti-Human, PE, Clone: BVD3-1F9, BD

Catalog No. BDB554676 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB554676 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB554676 Supplier BD Biosciences Supplier No. 554676
Add to Cart
Add to Cart

Description

Rat Monoclonal Antibody

The BVD3-1F9 antibody reacts with human interleukin-3 (IL-3). The immunogen used to generate the BVD3-1F9 hybridoma was recombinant human IL-3. This is a weakly neutralizing antibody.

Host Species: Rat
Clone: BVD3-1F9
Isotype: IgG1
Species Reactivity: Human
Immunogen: Recombinant Human IL-3

Intracellular Staining

TRUSTED_SUSTAINABILITY

Specifications

Antigen IL-3
Applications Flow Cytometry
Classification Monoclonal
Clone BVD3-1F9
Concentration 0.2mg/mL
Conjugate PE
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Host Species Rat
Immunogen Recombinant Human IL-3
Purification Method Affinity Purified
Quantity 0.1 mg
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Target Species Human
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Isotype IgG1
Show More Show Less

For Research Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.